Law360, New York (September 19, 2011, 7:41 PM ET) -- The U.S. Food and Drug Administration last week approved Sun Pharmaceutical Industries Ltd.’s corrective actions at a Cranbury, N.J., manufacturing plant cited last year for quality control violations that included imploding pill bottles and drug defects.
In a Sept. 13 letter, the FDA told Sun that after the agency's most recent inspection of the plant, the drugmaker appeared to have addressed a litany of current good manufacturing practices violations in a warning issued in August 2010.
Early last year, the FDA slammed Sun for poor handling...
Sun Pharma NJ Plant Passes FDA Review After Warning
To view the full article, take a free trial now.
